OverviewChartNewsTraderScreen

JP Morgan Call 205 PGR 16.08.2024/  DE000JB9P610  /

EUWAX
2024-06-28  10:28:34 AM Chg.+0.21 Bid2:26:31 PM Ask2:26:31 PM Underlying Strike price Expiration date Option type
1.39EUR +17.80% 1.45
Bid Size: 2,000		 1.51
Ask Size: 2,000		 Progressive Corporat... 205.00 USD 2024-08-16 Call
GlobeNewswire 2:00 PM Eyenovia Announces Pricing of $5M Registered Direct Offering
GlobeNewswire 1:00 PM Orchard Therapeutics Celebrates Global Progress toward Advancing Newborn Screening for MLD on Intern...
GlobeNewswire 12:57 PM Apellis Plans to Seek Re-Examination Following Negative CHMP Opinion for Pegcetacoplan for Geographi...
GlobeNewswire 7:00 AM XPPen to Showcase Diverse Innovative Products at Anime Expo 2024
GlobeNewswire 1:39 AM “LEQEMBI®” (Lecanemab) for the Treatment of Alzheimer’s Disease Launched in China
GlobeNewswire 12:30 AM Renalytix Submits Hearing Request to Nasdaq Hearings Panel in Regard to Staff Delisting Determinatio...
Newsfile Corp 06-27 APFC Coin (APFC) Is Now Available for Trading on LBank Exchange
GlobeNewswire 06-27 UFL CONCLUDES INAUGURAL SEASON WITH SIGNIFICANT GROWTH ACROSS KEY CONSUMER METRICS
GlobeNewswire 06-27 GRI Bio Announces Korea Patent Granted for Proprietary Natural Killer T (NKT) Cell Modulators
GlobeNewswire 06-27 Treating Geographic Atrophy Remains a Tough Call for Ophthalmologists as They Voice Hesitancy to Pre...
GlobeNewswire 06-25 argenx Highlights Breadth of Autoimmune Pipeline with New Multifocal Motor Neuropathy Data at 2024 P...
GlobeNewswire 06-25 AskBio Initiates Recruitment to its Phase 2 Parkinson’s Disease Trial
GlobeNewswire 06-24 Enlivex Announces the Dosing of the First Patient in a Randomized, Placebo-Controlled Phase I/II Tri...
GlobeNewswire 06-24 4DMT Announces FDA Clearance of IND Application for 4D-175 Genetic Medicine for the Treatment of Geo...
GlobeNewswire 06-24 Entrada Therapeutics Reports Positive Preliminary Data in Healthy Volunteers from Phase 1 ENTR-601-4...
GlobeNewswire 06-19 Opthea A$55.0m (US$36.9m¹) Retail Entitlement Offer Opens
GlobeNewswire 06-18 Afamelanotide in fair-skinned Parkinson’s patients
GlobeNewswire 06-14 Progressive Reports May 2024 Results
GlobeNewswire 06-13 Dyne Therapeutics Presents New Preclinical Data for its Facioscapulohumeral Muscular Dystrophy Progr...
GlobeNewswire 06-12 Ultragenyx Announces Plans to File for Accelerated Approval of UX111 for the Treatment of Sanfilippo...
GlobeNewswire 06-12 Belite Bio Receives Sakigake (Pioneer Drug) Designation of Tinlarebant for Stargardt Disease in Japa...
GlobeNewswire 06-11 Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D ...
GlobeNewswire 06-11 Processa Pharmaceuticals Announces Positive Efficacy Results from Preliminary Evaluation of Phase 1b...
GlobeNewswire 06-11 FDA Accepts Tiziana Life Sciences Fast Track Designation Submission for Treatment of Multiple Sclero...
GlobeNewswire 06-10 LifeWallet’s Proprietary Data System is Instrumental in Class Certification Against USAA Property an...